Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmitry Nemirovsky

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Mount Sinai Journal of Medicine, New York|December 17, 2005
Elevated homocysteine levels in patients with end-stage renal diseaseAjith P Nair, Dmitry Nemirovsky, Michael Kim, et al.
The Mount Sinai Journal of Medicine, New York|February 8, 2007
Multimodal characterization of a large right atrial mass after surgical repair of an atrial septal defectDmitry Nemirovsky, Sacha P Salzberg, Andrew J Einstein, et al.
Circulation|April 25, 2025
Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL TrialLouise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani, et al.
Circulation|November 15, 2021
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN TrialReinoud E Knops, Willeke van der Stuijt, Peter Paul H M Delnoy, et al.
Circulation. Arrhythmia and Electrophysiology|December 3, 2024
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN TrialLouise R A Olde Nordkamp, Shari Pepplinkhuizen, Abdul Ghani, et al.
European Heart Journal|August 28, 2022
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trialReinoud E Knops, Shari Pepplinkhuizen, Peter Paul H M Delnoy, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Mount Sinai Journal of Medicine, New York|December 17, 2005
Elevated homocysteine levels in patients with end-stage renal diseaseAjith P Nair, Dmitry Nemirovsky, Michael Kim, et al.
The Mount Sinai Journal of Medicine, New York|February 8, 2007
Multimodal characterization of a large right atrial mass after surgical repair of an atrial septal defectDmitry Nemirovsky, Sacha P Salzberg, Andrew J Einstein, et al.
Circulation|April 25, 2025
Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL TrialLouise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani, et al.
Circulation|November 15, 2021
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN TrialReinoud E Knops, Willeke van der Stuijt, Peter Paul H M Delnoy, et al.
Circulation. Arrhythmia and Electrophysiology|December 3, 2024
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN TrialLouise R A Olde Nordkamp, Shari Pepplinkhuizen, Abdul Ghani, et al.
European Heart Journal|August 28, 2022
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trialReinoud E Knops, Shari Pepplinkhuizen, Peter Paul H M Delnoy, et al.
Pageof 2